Mirum Pharmaceuticals Inc... (MIRM)
NASDAQ: MIRM
· Real-Time Price · USD
67.89
3.06 (4.72%)
At close: Aug 15, 2025, 3:59 PM
67.86
-0.04%
After-hours: Aug 15, 2025, 06:59 PM EDT
Mirum Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 429.16M | 379.25M | 336.89M | 307.03M | 264.38M | 224M | 186.37M | 144.73M | 115.78M | 95.77M | 77.06M | 52.29M | 38.51M | 32.03M | 19.14M | 16M | 11M | n/a |
Cost of Revenue | 90.03M | 86.83M | 81.64M | 81.47M | 70.89M | 57.47M | 44.62M | 26.51M | 19.22M | 14.93M | 12.37M | 9.78M | 6.85M | 4.33M | 2.09M | 185K | 185K | 185K |
Gross Profit | 339.14M | 292.42M | 255.25M | 225.56M | 193.49M | 166.52M | 141.75M | 118.21M | 96.56M | 80.84M | 64.69M | 42.51M | 31.66M | 27.7M | 17.05M | 15.81M | 10.81M | -185K |
Operating Income | -57.08M | -76.32M | -87.61M | -93.46M | -105.92M | -105.96M | -106.64M | -110.73M | -118.46M | -125.63M | -131.22M | -142.63M | -152.58M | -158.54M | -173.41M | -164.79M | -143.68M | -129.88M |
Interest Income | 12.73M | 13.18M | 13.79M | 14.36M | 14.96M | 15.1M | 13.73M | 12.1M | 9.39M | 6.06M | 3.86M | 1.78M | 499K | 286K | 366K | 469K | 634K | 959K |
Pretax Income | -57.36M | -75.91M | -86.91M | -95.47M | -104.92M | -154.64M | -159.91M | -163.28M | -175.63M | -135.41M | -142.07M | -48.22M | -59.63M | -70.02M | -83.95M | -178.71M | -153.12M | -132.49M |
Net Income | -58.56M | -77.34M | -87.94M | -97.3M | -106.65M | -156.05M | -160.91M | -164.19M | -176.31M | -129.19M | -135.66M | -41.69M | -53.09M | -70.06M | -83.99M | -178.74M | -153.13M | -132.49M |
Selling & General & Admin | 228.37M | 214.29M | 202.22M | 191.57M | 177.56M | 161.3M | 145.88M | 126.16M | 112.15M | 100.17M | 89.07M | 81.63M | 76.47M | 68.86M | 59.22M | 47.41M | 35.79M | 27.48M |
Research & Development | 167.85M | 154.45M | 140.63M | 127.44M | 121.85M | 111.19M | 102.52M | 102.78M | 102.88M | 106.3M | 106.84M | 103.51M | 107.77M | 117.38M | 131.43M | 133.38M | 118.89M | 102.4M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -192K | -192K | -346K | -346K | -189K | -189K | -51K | -134K | -129K | -185K |
Operating Expenses | 396.21M | 368.74M | 342.85M | 319.02M | 299.41M | 272.49M | 248.4M | 228.94M | 215.03M | 206.47M | 195.91M | 185.15M | 184.24M | 186.24M | 190.65M | 180.79M | 154.68M | 129.88M |
Interest Expense | 14.35M | 14.33M | 14.31M | 14.29M | 14.28M | 14.44M | 15.11M | 15.9M | 16.3M | 16.45M | 15.98M | 15.39M | 17.08M | 17.98M | 17.59M | 14.16M | 8.49M | 3.72M |
Selling & Marketing Expenses | -7.97M | n/a | n/a | 14.27M | 14.27M | 11.98M | 11.98M | 15.2M | 15.2M | 9.51M | 9.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 486.24M | 455.57M | 424.49M | 400.49M | 370.3M | 329.96M | 293.02M | 255.46M | 234.25M | 221.4M | 208.28M | 194.93M | 191.09M | 190.57M | 192.55M | 180.79M | 154.68M | 129.88M |
Income Tax Expense | 1.2M | 1.44M | 1.03M | 1.83M | 1.73M | 1.41M | 991K | 906K | 670K | -6.22M | -6.41M | -6.53M | -6.54M | 43K | 37K | 27K | 15K | 7K |
Shares Outstanding (Basic) | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 36.96M | 34.93M | 32.16M | 31.3M | 30.32M | 30.37M | 30.27M | 30.11M |
Shares Outstanding (Diluted) | 49.73M | 48.89M | 48.34M | 47.78M | 47.24M | 46.93M | 46.72M | 41.1M | 38.11M | 37.68M | 37.52M | 34.93M | 32.18M | 31.3M | 30.58M | 30.37M | 30.27M | 30.11M |
EPS (Basic) | -1.21 | -1.61 | -1.85 | -2.07 | -2.34 | -3.76 | -4.02 | -4.3 | -4.75 | -3.65 | -4.02 | -1.15 | -1.68 | -2.29 | -2.8 | -6.11 | -5.42 | -4.9 |
EPS (Diluted) | -1.21 | -1.61 | -1.85 | -2.07 | -2.34 | -3.76 | -4.02 | -4.28 | -4.73 | -3.63 | -4 | -1.15 | -1.68 | -2.29 | -2.8 | -6.11 | -5.42 | -4.9 |
EBITDA | -18.79M | -37.56M | -48.97M | -60.62M | -73.47M | -127.41M | -136.2M | -140.43M | -153.84M | -114.24M | -122.41M | -30.05M | -40.78M | -50.8M | -65.39M | -163.85M | -143.95M | -128.12M |
EBIT | -43.01M | -61.58M | -72.6M | -83.69M | -93.15M | -142.71M | -147.32M | -147.38M | -159.34M | -118.96M | -126.09M | -32.84M | -42.55M | -52.04M | -66.36M | -164.55M | -144.63M | -128.77M |
Depreciation & Amortization | 24.22M | 24.02M | 23.63M | 22.97M | 19.58M | 15.21M | 11.02M | 6.95M | 5.5M | 4.72M | 3.68M | 2.79M | 1.76M | 1.23M | 975K | 703K | 680K | 652K |